8-K: LifeStance Health Annual Meeting Voting Results
Annual Meeting Results
LifeStance Health Group, Inc. reports the successful election of directors and ratification of auditors at its 2026 annual meeting.
Summary
- LifeStance Health Group, Inc. held its annual meeting of stockholders on June 2, 2026.
- Stockholders elected David Bourdon and Robert Bessler as Class II directors for three-year terms.
- PricewaterhouseCoopers LLP was ratified as the independent registered public accounting firm for the 2026 fiscal year.
- Stockholders approved the advisory vote on named executive officer compensation.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as it represents standard corporate governance procedures without material impact on financial operations.
Positives
- Successful re-election of board members with significant shareholder support.
- Strong ratification of the independent auditor, indicating shareholder confidence in financial oversight.
- Approval of executive compensation packages, suggesting alignment between management and shareholders.
Negatives
- Notable withhold votes for director David Bourdon (83,966,052) compared to Robert Bessler (48,918,753).
Risks
- Potential for shareholder dissatisfaction regarding board composition given the volume of withhold votes for specific directors.
Future Outlook
No specific forward-looking financial guidance was provided in this filing.
Industry Context
StockSavvy.ai notes that routine annual meeting filings are standard for public companies and generally reflect stable corporate governance practices within the healthcare services sector.
Comparison to Industry Standards
- The ratification of auditors and approval of executive compensation are standard outcomes for U.S. publicly traded companies.
- Director election results are consistent with typical voting patterns for companies of similar market capitalization.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Board Election | Election of David Bourdon and Robert Bessler as Class II directors. | 2026-06-02 | Maintains continuity in board leadership. |
Stakeholder Impact
- Shareholders have confirmed the current board and executive compensation structure.
Next Steps
- Implementation of board decisions and continued engagement with shareholders.
Key Dates
| Date | Description |
|---|---|
| 2026-06-02 | Date of the Annual Meeting of Stockholders. |
| 2026-06-04 | Date of the filing of the Form 8-K. |
Keywords
LifeStance Health, LFST, Annual Meeting, Proxy Voting, Corporate Governance, Board Election
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.